Research Article
Volume 16 Issue 11 - 2021
Camellia sinensis and Euphorbia prostrata Nutraceutical Powder Formulation and Evaluation for Osteoarthritis Management
Were LL Munyendo1* and Apollo O Maima2
1School of Pharmacy and Health Sciences, United States International University - Africa, Nairobi, Kenya
2School of Medicine, Maseno University, Maseno, Kenya
*Corresponding Author: 2School of Medicine, Maseno University, Maseno, Kenya.
Received: September 13, 2021; Published: October 28, 2021


Osteoarthritis is becoming a common disorder among all age groups. Meanwhile bioactive nonfood matrices are realized to display desired therapeutic actions. Nutraceutical blends of Camellia sinensis and Euphorbia prostrata aqueous extract were prepared and evaluated as fast disintegrating granules. Formula optimization was achieved by a 23 Taguchi Orthogonal Arrays on Design Expert© Version 8.0 (freeware). Powder mix was then prepared by mixers then granules’ particle size, friability and densities for flowability evaluated. Anti-arthritic activity was tested biochemically by Bovine Serum denaturation and Egg Albumin Denaturation methods. Ethanol Soxhlet extractions yielded 22.8% and 17.8% percentage yields for C. sinensis and E. prostrata, respectively. The optimized blend ratio was 3:1 for C. sinensis : E. prostrata at a concentration of 2.5 µg.mL-1. This gave protein denaturation of only 6.0% implying a 94% protection compared to the control at 89.95%. An inhibition of 65% was recorded in egg albumin protein method. Angle of repose of 27o implied good flowability. Additionally, bulk and tapped densities were significantly low, indicating suitable powder particle packing. The C. sinensis - E. prostrata nutraceutical powder stands as a novel herbal-based solid dosage formulation with optimum rheological characteristics for rapid disintegration and osteoarthritis management adequacies.

Keywords: Nutraceuticals; Osteoarthritis; Powder; Flowability; Biochemical


  1. Van Der Kraan PM and Van Den Berg WB. “Anabolic and destructive mediators in osteoarthritis”. Current Opinion in Clinical Nutrition and Metabolic Care3 (2000): 205-211.
  2. Akhtar N and Haqqi TM. “Current nutraceuticals in the management of osteoarthritis: a review”. International Journal of Rheumatic Diseases3 (2012) 181-207.
  3. GBD. country results: a global public good”. Lancet 381.9871 (2013): 965-970.
  4. Fransen M., et al. “The epidemiology of osteoarthritis in Asia”. International Journal of Rheumatic Diseases2 (2011): 113-121.
  5. Oyoo O. “Rheumatic disorders in Kenya: Spectrum of disease”. Healthline4 (2004): 15-19.
  6. Beaglehole R., et al. “Priority actions for the non-communicable disease crisis”. Lancet 377 (2011): 1438-1447.
  7. Chan FK., et al. “A novel composite endpoint to evaluate the gastrointestinal (GI) effects of nonsteroidal anti-inflammatory drugs through the entire GI tract”. The Journal of Rheumatology 37 (2010): 167-174.
  8. Hajnal K., et al. “Prodrug strategy in drug development”. Acta Medica Marisiensis3 (2016): 356-362.
  9. Danesi F., et al. “Food-derived bioactives as polyphenol epigallocatechin-3-gallate inhibits advanced glycation end product induced potential regulators of the IL-12/IL-23 pathway implicated in inflammatory bowel diseases”. Mutation Research 690 (2010): 139-144.
  10. Katiyar SK and Raman C. “Green tea: a new option for the prevention or control of osteoarthritis”. Arthritis Research and Therapy 13 (2011): 121.
  11. Khalifé S and Zafarullah M. “Molecular targets of natural health products in arthritis”. Arthritis Research and Therapy 13 (2011): 102.
  12. Afzal M., et al. “Green tea polyphenols and their potential role in health and disease”. Inflammopharmacology 23 (2015): 151-161.
  13. Khalatbary AR and Khademi E. “The green tea polyphenolic catechin epigallocatechin gallate and neuroprotection”. Nutritional Neuroscience 25 (20118): 1-14.
  14. Smith A., et al. “Nanolipidic particles improve the bioavailability and alpha-secretase inducing ability of epigallocatechin-3-gallate (EGCG) for the treatment of Alzheimer’s disease”. International Journal of Pharmaceutics 389 (2010): 207-212.
  15. Ahmed S. “Green tea polyphenol epigallocatechin 3-gallate in arthritis: progress and promise”. Arthritis Research and Therapy2 (2010): 1-9.
  16. Saeed -Ul –Hassan S., et al. “Irritants effects of euphorbia prostrata”. African Journal of Pharmacy and Pharmacology 7 (2013): 2321-2332.
  17. Biwott T., et al. “Analgesic Properties of Euphorbia prostrata Crude Extracts Science”. Journal of Chemistry6 (2015): 100-105.
  18. Battu GR., et al. “Evaluation of antioxidant and anti-inflammatory activity of Euphorbia heyneana Spreng”. Asian Pacific Journal of Tropical Biomedicine2 (2011): 191-194.
  19. Gaur K., et al. “Anti-inflammatory and analgesic activity of hydro-alcoholic leaves extract of Euphorbia neriifolia Linn”. Asian Journal of Pharmaceutical and Clinical Research 1 (2009): 26-28.
  20. Raijni B., et al. “Isolation and evaluation of Hibiscus rosa-sinensis leaf mucilage as superdisintegrant”. European Journal of Pharmaceutical and Medical Research 8 (2016): 434-440.
  21. Deveswaran R., et al. “Evaluation of disintegrant properties of Plantago ovata mucilage in comparison with other superdisintegrants”. Archives of Pharmacal Research 2 (2010): 230-235.
  22. Sravani S and Sailaja P. “Formulation and Evaluation of Fast Dissolving Tablets of Felodipine”. Journal of Pharmacy 7 (2016): 104-112.
  23. Elmarzugi NA., et al. “Preformulation studies on Lactuca sativa as nutraceuticals granules”. Journal Teknologi2 (2013): 35-43.
  24. Rahman H., et al. “In-Vitro Studies Suggest Probable Mechanism Of Eucalyptus Oil For Anti-Inflammatory and Anti-Arthritic Activity”. International Journal of Phytopharmacy 3 (2012): 81-85.
  25. Álvarez R., et al. “Evaluation of Polyphenol Content and Antioxidant Capacity of Fruits and Vegetables Using a Modified Enzymatic Extraction”. Food Technology and Biotechnology 4 (2016): 462-467.
  26. Koc S., et al. “The potential medicinal value of plants from Asteraceae family with antioxidant defense enzymes as biological targets”. Pharmaceutical Biology 5 (2015): 746-751.
  27. Zhao C-N., et al. “Phenolic Profiles and Antioxidant Activities of 30 Tea Infusions from Green, Black, Oolong, White, Yellow and Dark Teas”. Antioxidants7 (2019): 215.
  28. Sigfridsson K., et al. “Preformulation investigation and challenges; salt formation, salt disproportionation and hepatic recirculation”. European Journal of Pharmaceutical Sciences 104 (2017): 262-272.
  29. Shirsand S Suresh S., et al. “Plantago ovata Mucilage in the Design of Fast Disintegrating Tablets”. Indian Journal of Pharmaceutical Sciences1 (2009): 41-44.
Citation: Were LL Munyendo and Apollo O Maima.,“ Camellia sinensis and Euphorbia prostrata Nutraceutical Powder Formulation and Evaluation for Osteoarthritis Management”. EC Nutrition 16.11 (2021): 03-13.

PubMed Indexed Article

EC Pharmacology and Toxicology
LC-UV-MS and MS/MS Characterize Glutathione Reactivity with Different Isomers (2,2' and 2,4' vs. 4,4') of Methylene Diphenyl-Diisocyanate.

PMID: 31143884 [PubMed]

PMCID: PMC6536005

EC Pharmacology and Toxicology
Alzheimer's Pathogenesis, Metal-Mediated Redox Stress, and Potential Nanotheranostics.

PMID: 31565701 [PubMed]

PMCID: PMC6764777

EC Neurology
Differences in Rate of Cognitive Decline and Caregiver Burden between Alzheimer's Disease and Vascular Dementia: a Retrospective Study.

PMID: 27747317 [PubMed]

PMCID: PMC5065347

EC Pharmacology and Toxicology
Will Blockchain Technology Transform Healthcare and Biomedical Sciences?

PMID: 31460519 [PubMed]

PMCID: PMC6711478

EC Pharmacology and Toxicology
Is it a Prime Time for AI-powered Virtual Drug Screening?

PMID: 30215059 [PubMed]

PMCID: PMC6133253

EC Psychology and Psychiatry
Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse.

PMID: 30417173 [PubMed]

PMCID: PMC6226033

EC Anaesthesia
Arrest Under Anesthesia - What was the Culprit? A Case Report.

PMID: 30264037 [PubMed]

PMCID: PMC6155992

EC Orthopaedics
Distraction Implantation. A New Technique in Total Joint Arthroplasty and Direct Skeletal Attachment.

PMID: 30198026 [PubMed]

PMCID: PMC6124505

EC Pulmonology and Respiratory Medicine
Prevalence and factors associated with self-reported chronic obstructive pulmonary disease among adults aged 40-79: the National Health and Nutrition Examination Survey (NHANES) 2007-2012.

PMID: 30294723 [PubMed]

PMCID: PMC6169793

EC Dental Science
Important Dental Fiber-Reinforced Composite Molding Compound Breakthroughs

PMID: 29285526 [PubMed]

PMCID: PMC5743211

EC Microbiology
Prevalence of Intestinal Parasites Among HIV Infected and HIV Uninfected Patients Treated at the 1o De Maio Health Centre in Maputo, Mozambique

PMID: 29911204 [PubMed]

PMCID: PMC5999047

EC Microbiology
Macrophages and the Viral Dissemination Super Highway

PMID: 26949751 [PubMed]

PMCID: PMC4774560

EC Microbiology
The Microbiome, Antibiotics, and Health of the Pediatric Population.

PMID: 27390782 [PubMed]

PMCID: PMC4933318

EC Microbiology
Reactive Oxygen Species in HIV Infection

PMID: 28580453 [PubMed]

PMCID: PMC5450819

EC Microbiology
A Review of the CD4 T Cell Contribution to Lung Infection, Inflammation and Repair with a Focus on Wheeze and Asthma in the Pediatric Population

PMID: 26280024 [PubMed]

PMCID: PMC4533840

EC Neurology
Identifying Key Symptoms Differentiating Myalgic Encephalomyelitis and Chronic Fatigue Syndrome from Multiple Sclerosis

PMID: 28066845 [PubMed]

PMCID: PMC5214344

EC Pharmacology and Toxicology
Paradigm Shift is the Normal State of Pharmacology

PMID: 28936490 [PubMed]

PMCID: PMC5604476

EC Neurology
Examining those Meeting IOM Criteria Versus IOM Plus Fibromyalgia

PMID: 28713879 [PubMed]

PMCID: PMC5510658

EC Neurology
Unilateral Frontosphenoid Craniosynostosis: Case Report and a Review of the Literature

PMID: 28133641 [PubMed]

PMCID: PMC5267489

EC Ophthalmology
OCT-Angiography for Non-Invasive Monitoring of Neuronal and Vascular Structure in Mouse Retina: Implication for Characterization of Retinal Neurovascular Coupling

PMID: 29333536 [PubMed]

PMCID: PMC5766278

EC Neurology
Longer Duration of Downslope Treadmill Walking Induces Depression of H-Reflexes Measured during Standing and Walking.

PMID: 31032493 [PubMed]

PMCID: PMC6483108

EC Microbiology
Onchocerciasis in Mozambique: An Unknown Condition for Health Professionals.

PMID: 30957099 [PubMed]

PMCID: PMC6448571

EC Nutrition
Food Insecurity among Households with and without Podoconiosis in East and West Gojjam, Ethiopia.

PMID: 30101228 [PubMed]

PMCID: PMC6086333

EC Ophthalmology
REVIEW. +2 to +3 D. Reading Glasses to Prevent Myopia.

PMID: 31080964 [PubMed]

PMCID: PMC6508883

EC Gynaecology
Biomechanical Mapping of the Female Pelvic Floor: Uterine Prolapse Versus Normal Conditions.

PMID: 31093608 [PubMed]

PMCID: PMC6513001

EC Dental Science
Fiber-Reinforced Composites: A Breakthrough in Practical Clinical Applications with Advanced Wear Resistance for Dental Materials.

PMID: 31552397 [PubMed]

PMCID: PMC6758937

EC Microbiology
Neurocysticercosis in Child Bearing Women: An Overlooked Condition in Mozambique and a Potentially Missed Diagnosis in Women Presenting with Eclampsia.

PMID: 31681909 [PubMed]

PMCID: PMC6824723

EC Microbiology
Molecular Detection of Leptospira spp. in Rodents Trapped in the Mozambique Island City, Nampula Province, Mozambique.

PMID: 31681910 [PubMed]

PMCID: PMC6824726

EC Neurology
Endoplasmic Reticulum-Mitochondrial Cross-Talk in Neurodegenerative and Eye Diseases.

PMID: 31528859 [PubMed]

PMCID: PMC6746603

EC Psychology and Psychiatry
Can Chronic Consumption of Caffeine by Increasing D2/D3 Receptors Offer Benefit to Carriers of the DRD2 A1 Allele in Cocaine Abuse?

PMID: 31276119 [PubMed]

PMCID: PMC6604646

EC Anaesthesia
Real Time Locating Systems and sustainability of Perioperative Efficiency of Anesthesiologists.

PMID: 31406965 [PubMed]

PMCID: PMC6690616

EC Pharmacology and Toxicology
A Pilot STEM Curriculum Designed to Teach High School Students Concepts in Biochemical Engineering and Pharmacology.

PMID: 31517314 [PubMed]

PMCID: PMC6741290

EC Pharmacology and Toxicology
Toxic Mechanisms Underlying Motor Activity Changes Induced by a Mixture of Lead, Arsenic and Manganese.

PMID: 31633124 [PubMed]

PMCID: PMC6800226

EC Neurology
Research Volunteers' Attitudes Toward Chronic Fatigue Syndrome and Myalgic Encephalomyelitis.

PMID: 29662969 [PubMed]

PMCID: PMC5898812

EC Pharmacology and Toxicology
Hyperbaric Oxygen Therapy for Alzheimer's Disease.

PMID: 30215058 [PubMed]

PMCID: PMC6133268

News and Events

September Issue Release

We always feel pleasure to share our updates with you all. Here, notifying you that we have successfully released the September issue of respective journals and the latest articles can be viewed on the current issue pages.

Submission Deadline for Upcoming Issue

ECronicon delightfully welcomes all the authors around the globe for effective collaboration with an article submission for the upcoming issue of respective journals. Submissions are accepted on/before October 14, 2022.

Certificate of Publication

ECronicon honors with a "Publication Certificate" to the corresponding author by including the names of co-authors as a token of appreciation for publishing the work with our respective journals.

Best Article of the Issue

Editors of respective journals will always be very much interested in electing one Best Article after each issue release. The authors of the selected article will be honored with a "Best Article of the Issue" certificate.

Certifying for Review

ECronicon certifies the Editors for their first review done towards the assigned article of the respective journals.

Latest Articles

The latest articles will be updated immediately on the articles in press page of the respective journals.